Results 101 to 110 of about 29,158 (227)

Paricalcitol for secondary hyperparathyroidism in renal transplantation

open access: yes, 2015
Secondary hyperparathyroidism contributes to post-transplant CKD mineral and bone disorder. Paricalcitol, a selective vitamin D receptor activator, decreased serum parathyroid hormone levels and proteinuria in patients with secondary hyperparathyroidism.
A. Perna   +15 more
core   +1 more source

Tooth mobility revealing a brown tumor associated with normocalcemic hyperparathyroidism: case report and literature review

open access: yesBMC Oral Health
Background Brown tumors are rare non-neoplastic bone lesions associated with hyperparathyroidism. They are uncommon in the jaws and are usually linked to primary or secondary hyperparathyroidism, while tertiary hyperparathyroidism is rarely reported ...
Sara Boukssim   +2 more
doaj   +1 more source

Reversal of uremic tumoral calcinosis by optimization of clinical treatment of bone and mineral metabolism disorder

open access: yesBrazilian Journal of Nephrology
Tumoral calcinosis is an uncommon type of extraosseous calcification characterized by large rubbery or cystic masses containing calcium-phosphate deposits. The condition prevails in the periarticular tissue with preservation of osteoarticular structures.
Mariana Espiga Maioli   +4 more
doaj   +1 more source

Osteitis Fibrosa Cystica; A Forgotten Manifestation of Secondary Hyperparathyroidism Due to End-Stage Renal Disease: A Case Report

open access: yesInternational Medical Case Reports Journal, 2022
Semir Abdi Usmael,1 Sisay Molla Ansa,1 Derejie Woldesilasie Tufa2 1Department of Internal Medicine, Haramaya University, College of Health and Medical Science, Harar, Ethiopia; 2Department of Radiology, Haramaya University, College of Health and Medical ...
Usmael SA, Ansa SM, Tufa DW
doaj  

2 cases of surgical experience of secondary hyperparathyroidism

open access: yes, 1995
Secondary hyperparathyroidism is the condition is which increased parathyroid hormone(PTH) is secreted to compensate for a chronically low calcium level and chronic renal failure is the most common cause. In 1934, Albreight reported an assocition between
공병엽, 홍석준, 박수길
core  

Hyperparathyroidism secondary to hyperaldosteronism

open access: yes, 2010
Introduction: Hyperparathyroidism has been associated with essential hypertension. In rats, volume expansion, the deoxycorticosterone (DOC)-salt hypertension model and primary aldosteronism cause a reduction in plasma calcium levels and secondary ...
Fortina F., Bellosta S.
core   +1 more source

Rifampicin-induced Secondary Hyperparathyroidism in a Case of Isoniazid Monoresistant Pulmonary Tuberculosis

open access: yesThe Journal of Association of Chest Physicians
Antitubercular drug (ATD)-induced hypovitaminosis D3 and secondary hyperparathyroidism are less reported phenomena compared to other antitubercular therapy–induced adverse events.
Indra Kishor Saha   +3 more
doaj   +1 more source

Surgical treatment of secondary hyperparathyroidism

open access: yes, 2000
BACKGROUND: Surgical treatment in the patient effected by secondary hyperparathyroidism consists in subtotal parathyroidectomy or total parathyroidectomy plus autotransplantation of parathyroid tissue.
CARACO C   +5 more
core  

Prospective evaluation of total parathyroidectomy and autotransplantation for the treatment of secondary hyperparathyroidism

open access: yes, 1999
Objective: To evaluate the clinical effectiveness of total parathyroidectomy with autotransplantation for the treatment of hyperparathyroidism and the recurrence rate of hyperparathyroidism after this procedure.
A. Saputelli   +5 more
core   +1 more source

Secondary Hyperparathyroidism Mimicking Osteomyelitis

open access: yes, 2019
Introduction: With the advent of dialysis technology, patients with end stage renal disease have improved mortality; however, renal replacement is not without its own burdens, including endocrine disturbances such as secondary hyperparathyroidism. Though
Chen, Anne, Hadied, Mohamad, Hsia, Tammy
core  

Home - About - Disclaimer - Privacy